An overview of the efficacy and tolerability of new antiepileptic drugs

Epilepsia

Volumn 38, Issue SUPPL. 1, 1997, Pages

  Chadwick, D W ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Anticonvulsants; Controlled clinical trials; Drug toxicity; Gabapentin; Lamotrigine; Tiagabine; Topiramate; Vigabatrin; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LAMOTRIGINE; TIAGABINE; TOPIRAMATE; VIGABATRIN; ZONISAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; EPILEPSY; HUMAN; PRIORITY JOURNAL;

EID: 0030939641     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb04522.x     Document Type: Conference Paper

References (4)

1. Chadwick D, Marson AG, Kadir ZA. The clinical use of new antiepileptic drugs: an overview of safety and efficacy. Epilepsia (submitted).
2. Marson AG, Kadir ZA, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313:1169-74.
3. Marson AG, Chadwick DW. Comparing antiepileptic drugs. Curr Opin Neurol 1996;9:103-6.
4. Commission of Antiepileptic Drugs of the International League Against Epilepsy. Guidelines for antiepileptic drug trials in children. Epilepsia 1994;35:94-100.